PT2429502T - Método e composição para melhorar a absorção de aspirina - Google Patents

Método e composição para melhorar a absorção de aspirina

Info

Publication number
PT2429502T
PT2429502T PT10775187T PT10775187T PT2429502T PT 2429502 T PT2429502 T PT 2429502T PT 10775187 T PT10775187 T PT 10775187T PT 10775187 T PT10775187 T PT 10775187T PT 2429502 T PT2429502 T PT 2429502T
Authority
PT
Portugal
Prior art keywords
composition
therapeutic agents
improve absorption
absorption
improve
Prior art date
Application number
PT10775187T
Other languages
English (en)
Inventor
First Eric R
B Patel Ashish
Schmitz Guido
Petaway-Hickson Stephanie
Tong Hung-Huar
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43062708&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2429502(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of PT2429502T publication Critical patent/PT2429502T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT10775187T 2009-05-11 2010-05-10 Método e composição para melhorar a absorção de aspirina PT2429502T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/387,977 US11135188B2 (en) 2009-05-11 2009-05-11 Method and composition to improve absorption of therapeutic agents

Publications (1)

Publication Number Publication Date
PT2429502T true PT2429502T (pt) 2019-03-29

Family

ID=43062708

Family Applications (1)

Application Number Title Priority Date Filing Date
PT10775187T PT2429502T (pt) 2009-05-11 2010-05-10 Método e composição para melhorar a absorção de aspirina

Country Status (15)

Country Link
US (1) US11135188B2 (pt)
EP (1) EP2429502B1 (pt)
AR (1) AR076864A1 (pt)
BR (1) BRPI1013509A2 (pt)
CA (1) CA2761678A1 (pt)
CL (1) CL2011002807A1 (pt)
CO (1) CO6460753A2 (pt)
EA (1) EA201171399A1 (pt)
HU (1) HUE043173T2 (pt)
MX (1) MX2011011928A (pt)
PL (1) PL2429502T3 (pt)
PT (1) PT2429502T (pt)
SI (1) SI2429502T1 (pt)
UY (1) UY32624A (pt)
WO (1) WO2010132095A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11135188B2 (en) 2009-05-11 2021-10-05 Bayer Healthcare Llc Method and composition to improve absorption of therapeutic agents
WO2014122195A1 (en) * 2013-02-06 2014-08-14 Hermes Arzneimittel Gmbh Pharmaceutical compositions incorporating low-dose drugs
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
PT3154528T (pt) 2014-06-11 2023-06-22 SpecGx LLC Composições secas por pulverização possuindo diferentes perfis de dissolução e processos para a sua preparação
CA2955229C (en) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
US11197830B2 (en) * 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
MX2023005639A (es) * 2020-11-13 2023-09-22 Bayer Healthcare Llc Comprimidos de capa doble orales que comprenden acido acetilsalicilico y pseudoefedrina, metodos para preparar y utilizar los mismos.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB191225486A (en) 1912-11-06 1913-04-24 Herbert Sefton-Jones Manufacture and Production of Improved Pharmaceutical Preparations.
US2293359A (en) 1941-01-08 1942-08-18 Quisling Sverre Acetyl salicylic acid preparation
FI89004C (fi) 1988-02-16 1993-08-10 Pertti J Neuvonen Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat
RU2099058C1 (ru) 1992-06-15 1997-12-20 Институт химии твердого тела и переработки минерального сырья СО РАН Способ получения твердой быстрорастворимой дисперсной системы, содержащей ацетилсалициловую кислоту
US5665388A (en) 1995-11-13 1997-09-09 Health Corporation Method for preparation of an alkaline and aspirin combination compound
ZA987800B (en) 1997-08-27 1999-06-09 Hexal Ag Pharmaceutical composition of meloxicam
US8231899B2 (en) * 1998-09-10 2012-07-31 Nycomed Danmark Aps Quick release pharmaceutical compositions of drug substances
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
RU2170582C1 (ru) 2000-02-17 2001-07-20 Институт химии твердого тела и механохимии СО РАН Способ получения быстрорастворимой таблетированной формы ацетилсалициловой кислоты
WO2005105102A1 (en) 2004-05-04 2005-11-10 Equitech Corporation Improved nsaid composition
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
GEP20094671B (en) * 2004-06-29 2009-04-27 Nycomed Danmark Aps Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention
ES2409347T3 (es) * 2004-10-21 2013-06-26 Aptalis Pharmatech, Inc. Composiciones farmacéuticas de sabor enmascarado con agentes porogénicos gastrosolubles
CA2629904C (en) 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US11135188B2 (en) 2009-05-11 2021-10-05 Bayer Healthcare Llc Method and composition to improve absorption of therapeutic agents

Also Published As

Publication number Publication date
PL2429502T3 (pl) 2019-07-31
UY32624A (es) 2010-12-31
US20100286100A1 (en) 2010-11-11
CA2761678A1 (en) 2010-11-18
SI2429502T1 (sl) 2019-05-31
CO6460753A2 (es) 2012-06-15
MX2011011928A (es) 2011-12-06
WO2010132095A1 (en) 2010-11-18
EP2429502A4 (en) 2012-10-24
EA201171399A1 (ru) 2012-05-30
EP2429502A1 (en) 2012-03-21
US11135188B2 (en) 2021-10-05
WO2010132095A8 (en) 2011-07-07
BRPI1013509A2 (pt) 2016-04-05
CL2011002807A1 (es) 2012-06-15
AR076864A1 (es) 2011-07-13
EP2429502B1 (en) 2018-12-26
HUE043173T2 (hu) 2019-08-28

Similar Documents

Publication Publication Date Title
EP2429502A4 (en) METHOD AND COMPOSITION FOR ENHANCING THE ABSORPTION OF THERAPEUTIC AGENTS
IL250314A0 (en) Enantiomers of spiro-exindole type substances and their use for the preparation of medical preparations
EP2448581A4 (en) THERAPEUTIC COMPOSITIONS AND METHODS OF USE THEREOF
HK1199828A1 (en) Compositions and methods for stimulating magp-1 to improve the appearance of skin magp-1
HK1173654A1 (zh) 治療化合物及相關的使用方法
EP2536738A4 (en) METHODS AND COMPOSITIONS SUITABLE FOR THE TREATMENT OF CONDITIONS OR CONDITIONS IN RELATION TO THE EXPANSION OF REPETITIONS
HK1150839A1 (en) Compositions and methods of use for therapeutic antibodies
EP2498772A4 (en) COMPOSITIONS AND METHODS FOR IMPROVING SKIN APPEARANCE
EP2501666A4 (en) PROCESS FOR PURIFYING AND STABILIZING CHLOROOLEFINS
EP2432462A4 (en) OXYGEN PROCEDURE AND COMPOSITIONS FOR THE TREATMENT OF MAMMALIAN DISEASES
HK1164832A1 (en) Piceatannol-containing composition and method of producing piceatannol- containing composition
IL218212A0 (en) Therapeutic methods and compositions
GB0902040D0 (en) Composition for treatment of skin
EP2515652A4 (en) COMPOSITIONS AND METHODS FOR TREATING VITILIGO
IL215093A0 (en) Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
EP2461870A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
EP2381950A4 (en) COMPOSITIONS AND METHOD FOR THEIR USE
EP2470016A4 (en) SYNERGISTIC COMPOSITION AND METHOD OF USE